Issue 7, 2022

Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial

Abstract

Expression of concern for ‘Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial’ by Alireza Mafi et al., Food Funct., 2018, 9, 4763–4770, DOI: https://doi.org/10.1039/C8FO00888D.

Associated articles

Article information

Article type
Expression of Concern
Submitted
14 Mar 2022
Accepted
14 Mar 2022
First published
21 Mar 2022
This article is Open Access
Creative Commons BY license

Food Funct., 2022,13, 4229-4229

Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial

P. Ross, Food Funct., 2022, 13, 4229 DOI: 10.1039/D2FO90024F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements